Algorae Pharmaceuticals (STU:LHI0) Accounts Payable & Accrued Expense : €0.07 Mil (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Algorae Pharmaceuticals Accounts Payable & Accrued Expense?

Algorae Pharmaceuticals's quarterly accounts payable & accrued expense increased from Dec. 2022 (€0.00 Mil) to Jun. 2023 (€0.25 Mil) but then declined from Jun. 2023 (€0.25 Mil) to Dec. 2023 (€0.07 Mil).

Algorae Pharmaceuticals's annual accounts payable & accrued expense increased from Jun. 2021 (€0.11 Mil) to Jun. 2022 (€0.13 Mil) and increased from Jun. 2022 (€0.13 Mil) to Jun. 2023 (€0.25 Mil).

Algorae Pharmaceuticals Accounts Payable & Accrued Expense Historical Data

The historical data trend for Algorae Pharmaceuticals's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Algorae Pharmaceuticals Accounts Payable & Accrued Expense Chart

Algorae Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.95

0.12

0.11

0.13

0.25

Algorae Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															0.22	0.13	-	0.25	0.07

Algorae Pharmaceuticals Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Algorae Pharmaceuticals (STU:LHI0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Algorae Pharmaceuticals Ltd (STU:LHI0) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

LVCLY:USA LVCLF:USA 1AI:Australia

Address

201 Sussex Street, Level 16, Tower 2, Darling Park, Sydney, NSW, AUS, 2000

Website

https://www.algoraepharma.com

Algorae Pharmaceuticals Ltd is a clinical-stage pharmaceutical company developing transformative solutions for undermet medical needs in the community. The firm develops AlgoraeOS, a closed-loop platform, leveraging computational tools to generate novel insights in silico that are being developed to initiate or accelerate therapeutic programs. Its lead products comprise AI-116, a novel combination drug candidate of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. It is conceptualised to be a potential treatment for dementia, including Alzheimer's disease; NTCELL is an alginate-coated capsule containing clusters of neonatal porcine choroid plexus cells. It also offers LP-003 Anti-obesity Drug and LC-002 migraine treatment.

Algorae Pharmaceuticals (STU:LHI0) Headlines

No Headlines